These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12414622

  • 1. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
    Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2002 Nov 01; 62(21):6021-5. PubMed ID: 12414622
    [Abstract] [Full Text] [Related]

  • 2. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2003 Sep 15; 63(18):5859-65. PubMed ID: 14522910
    [Abstract] [Full Text] [Related]

  • 3. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F, Strand DW, Rowley DR.
    Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743
    [Abstract] [Full Text] [Related]

  • 5. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR.
    Clin Cancer Res; 2002 Sep 17; 8(9):2912-23. PubMed ID: 12231536
    [Abstract] [Full Text] [Related]

  • 6. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 7. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A, Wang L, López-Casillas F, Mendoza V, Yeh IT, Sun L.
    Prostate; 2005 Apr 01; 63(1):81-90. PubMed ID: 15468171
    [Abstract] [Full Text] [Related]

  • 8. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 01; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
    Bandyopadhyay A, López-Casillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun LZ.
    Cancer Res; 2002 Aug 15; 62(16):4690-5. PubMed ID: 12183427
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
    Nilsson UW, Jönsson JA, Dabrosin C.
    Exp Cell Res; 2009 Jan 01; 315(1):1-9. PubMed ID: 18996114
    [Abstract] [Full Text] [Related]

  • 11. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
    Cheng L, Zhang S, Sweeney CJ, Kao C, Gardner TA, Eble JN.
    Anticancer Res; 2004 Jan 01; 24(4):2135-40. PubMed ID: 15330153
    [Abstract] [Full Text] [Related]

  • 12. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.
    Corallini A, Possati L, Trabanelli C, Giraudo E, Rocchetti R, Talevi S, Caputo A, Bussolino F, Barbanti-Brodano G.
    Carcinogenesis; 2003 Sep 01; 24(9):1435-44. PubMed ID: 12844479
    [Abstract] [Full Text] [Related]

  • 13. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 14. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 01; 12(9):933-9. PubMed ID: 14504208
    [Abstract] [Full Text] [Related]

  • 15. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.
    Gohongi T, Fukumura D, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T, Jain RK.
    Nat Med; 1999 Oct 01; 5(10):1203-8. PubMed ID: 10502827
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S, Li L, Ma JY, Kapoun AM, Gaspar NJ, Liu YW, Mangadu R, O'Young G, Protter AA, Schreiner GF, Wong DH, Higgins LS.
    Anticancer Res; 2007 Oct 01; 27(6B):4149-57. PubMed ID: 18229422
    [Abstract] [Full Text] [Related]

  • 17. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P.
    Mech Ageing Dev; 2005 Jan 01; 126(1):59-69. PubMed ID: 15610763
    [Abstract] [Full Text] [Related]

  • 18. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis.
    Santamaria-Martínez A, Barquinero J, Barbosa-Desongles A, Hurtado A, Pinós T, Seoane J, Poupon MF, Morote J, Reventós J, Munell F.
    Exp Cell Res; 2009 Oct 15; 315(17):3004-13. PubMed ID: 19447103
    [Abstract] [Full Text] [Related]

  • 19. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J, Wang A, Hu Q, Lu S, Dong Z.
    Int J Oncol; 2006 Dec 01; 29(6):1405-12. PubMed ID: 17088978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.